Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Current Assets

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹444 Cr₹1,322 Cr₹4,446 Cr₹2,461 Cr₹1,780 Cr

What is the latest Net Current Assets ratio of MANKIND PHARMA ?

The latest Net Current Assets ratio of MANKIND PHARMA is ₹444 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹444 Cr
Mar2025₹1,322 Cr
Mar2024₹4,446 Cr
Mar2023₹2,461 Cr
Mar2022₹1,780 Cr

How is Net Current Assets of MANKIND PHARMA Trending?

Years Net Current Assets % Change
Mar2026 ₹444 Cr
-66.40
Mar2025 ₹1,322 Cr
-70.26
Mar2024 ₹4,446 Cr
80.62
Mar2023 ₹2,461 Cr
38.25
Mar2022 ₹1,780 Cr -

Compare Net Current Assets of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹100,152.5 Cr -1.1% -3.4% -7.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹465,471.0 Cr -0.5% 0.8% 19% Stock Analytics
DIVIS LABORATORIES ₹226,631.0 Cr 2.2% 23.1% 27.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,157.0 Cr -2.6% -1.6% 36% Stock Analytics
CIPLA ₹118,108.0 Cr 0.8% 2.5% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,578.0 Cr 2.6% -2.4% -5.6% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.1%

-3.4%

-7.2%

SENSEX

-0.4%

0.8%

-3%


You may also like the below Video Courses